Trials / Unknown
UnknownNCT02882893
Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines
Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines: Active Controlled, Double-blind, Randomized, Multi-center, Phase II/III Clinical Trial
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 238 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the Efficacy and Safety of DWP450 treatment of Crows Feet Lines(CFL).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clostridium Botulinum A Toxin | |
| DRUG | Clostridium Botulinum A Toxin |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2017-01-01
- Completion
- 2017-04-01
- First posted
- 2016-08-30
- Last updated
- 2016-08-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02882893. Inclusion in this directory is not an endorsement.